A recent European study has found a surprising link between a widely used drug for high blood pressure, nifedipine, and an increased risk of sudden cardiac arrest.
This condition, where the heart abruptly stops pumping blood, is life-threatening and often fatal if not treated immediately.
Sudden cardiac arrest is a leading cause of death, responsible for half of all heart-related fatalities in Europe and one in five natural deaths. It strikes quickly, often without warning, though some people may experience symptoms like chest pain, shortness of breath, or nausea beforehand.
Once the heart stops, the person loses consciousness and stops breathing, requiring immediate intervention such as CPR or a defibrillator to survive.
In this study, researchers examined two drugs commonly prescribed for high blood pressure and chest pain: nifedipine and amlodipine.
Both belong to a class of medications that relax blood vessels and improve blood flow. They are taken by millions of people worldwide and have been considered safe for decades.
The researchers analyzed data from 2,503 patients who had experienced sudden cardiac arrest, comparing them to 10,543 healthy individuals in Amsterdam.
Their findings showed that people taking high doses of nifedipine (60 mg per day) had a higher likelihood of sudden cardiac arrest than those not taking the drug. By contrast, the other drug, amlodipine, did not show the same risk.
To confirm these findings, the team reviewed data from a second large group in Denmark, including 8,101 patients and 40,505 healthy individuals.
This analysis supported the initial results, reinforcing the link between high doses of nifedipine and an increased risk of sudden heart stoppage.
This discovery is unexpected, given that nifedipine and amlodipine have been widely used without major safety concerns.
However, sudden cardiac arrest is a particularly challenging condition to study because it occurs so quickly and often leads to death, making it difficult to collect detailed data. Earlier research may not have identified this potential risk due to these challenges.
While the study suggests a concerning association, researchers emphasize that more studies are needed to confirm the findings. They advise that patients should not stop taking nifedipine without consulting their doctor, as untreated high blood pressure can also lead to severe complications.
Instead, patients and doctors should discuss the findings and consider whether a lower dose or an alternative medication might be more appropriate.
This study highlights the importance of ongoing research, even for medications that have been in use for many years. New evidence can reshape our understanding of drug safety and lead to better treatment strategies.
For now, the key takeaway is to use nifedipine carefully, especially in high doses, and to remain vigilant about potential risks.
In summary, the research suggests that a high dose of nifedipine may increase the risk of sudden cardiac arrest, a discovery that underscores the importance of re-evaluating even well-established medications.
Open communication between patients and doctors is essential to ensure that high blood pressure is managed effectively while minimizing any potential risks. Further studies will be crucial to confirm these findings and guide future treatment recommendations.
If you care about heart failure, please read studies about diabetes drug that could revolutionize heart failure treatment, and this drug can be a low-cost heart failure treatment
For more information about heart health, please see recent studies that exercise in middle age reversed worrisome heart failure, and results showing this drug combo can cut risk of stroke and heart attack by half.
Copyright © 2024 Knowridge Science Report. All rights reserved.
